ClinicalTrials.Veeva

Menu

Propolis Extract, Nanovitamin C and Nanovitamin E in Peri-implant Mucositis

U

Universidad Complutense de Madrid

Status

Completed

Conditions

Peri-implant Mucositis

Treatments

Device: Gel containing propolis extract, nanovitamin C and nanovitamin E
Device: Placebo

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The objective of this study was to perform the first clinical trial to evaluate the effectiveness of propolis extract, nanovitamin C and nanovitamin E gel as adjuvant to mechanical debridement in clinical and microbiological parameters of implants with peri-implant mucositis

Enrollment

46 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • cooperative adult patients,
  • with one or more implants with peri-implant mucositis, and
  • presenting at least 18 months of functional loading.

Exclusion criteria

  • refuse to participate in the study,
  • patients who had implants with peri-implantitis (BOP and/or suppuration together with progressive radiographic marginal bone loss),
  • patients with uncontrolled periodontitis (presence of nine or more sites with PD ≥ 5 mm and with full-mouth bleeding score (FMBS) > 25%),
  • systemic diseases or conditions that could alter the results of the study (diabetes mellitus, immunosuppression, infectious diseases, rheumatoid disease, history of bisphosphonate treatment, radiotherapy, chemotherapy, etc.),
  • patients who had taken local and/or systemic antibiotics less than 2 months ago,
  • pregnant or breastfeeding women, and
  • patients with history of allergies to the test and/or placebo components administered.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

46 participants in 2 patient groups, including a placebo group

Test group
Experimental group
Description:
Gel contained in tubes with the same appearance (30g), identical in colour, flavour and density, with the following components: Sodium-Monofluorophosphate, Silicon Dioxide, Glycerin, D-sorbitol, Polyethylene glycol, Sodium Carboxymethylcellulose, Xylitol, Sterol Glycoside, Peppermint Oil, L-Menthol, Methyl Hydroxybenzoate, Deionized Water, Propolis Extract (2%), Ascorbic Acid (0.2%) and Tocopherol Acetate (0.2%).
Treatment:
Device: Gel containing propolis extract, nanovitamin C and nanovitamin E
Placebo group
Placebo Comparator group
Description:
Gel contained in tubes with the same appearance (30g), identical in colour, flavour and density, with the following components: Sodium-Monofluorophosphate, Silicon Dioxide, Glycerin, D-sorbitol, Polyethylene glycol, Sodium Carboxymethylcellulose, Xylitol, Sterol Glycoside, Peppermint Oil, L-Menthol, Methyl Hydroxybenzoate, Deionized Water and E155/151 coloring.
Treatment:
Device: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems